Amundi Trims Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Amundi decreased its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 19.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 48,795 shares of the company’s stock after selling 11,987 shares during the quarter. Amundi’s holdings in Intellia Therapeutics were worth $587,000 at the end of the most recent quarter. […]
Amundi decreased its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 19.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 48,795 shares of the company’s stock after selling 11,987 shares during the quarter. Amundi’s holdings in Intellia Therapeutics were worth $587,000 at the end of the most recent quarter. […]
